Skandinaviska Enskilda Banken (SEB)
APEN

Skandinaviska Enskilda Banken (SEB)’s Apollo Endosurgery, Inc. APEN Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-100,000
Closed -$992K – 999
2023
Q1 		$992K Buy
+100,000
New +$991K 0.01% 690

Skandinaviska Enskilda Banken (SEB)'s APEN Position: Q2 2023 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 100,000 shares — an estimated $992K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in APEN in Q1 2023 and held it in 1 quarter. The position peaked at $992K in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 100,000 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $992K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Apollo Endosurgery, Inc. in Q1 2023 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s Apollo Endosurgery, Inc. position peaked at $992K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2023, filed 7 Aug 2023.